| 000 | 01021 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512043950.0 | ||
| 264 | 0 | _c19880307 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0031-4005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerlman, M | |
| 245 | 0 | 0 |
_aBilirubin beyond the blood-brain barrier. _h[electronic resource] |
| 260 |
_bPediatrics _cFeb 1988 |
||
| 300 |
_a304-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBilirubin _xmetabolism |
| 650 | 0 | 4 | _aBlood-Brain Barrier |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEvoked Potentials, Somatosensory _xdrug effects |
| 650 | 0 | 4 | _aExchange Transfusion, Whole Blood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aJaundice, Neonatal _xtherapy |
| 650 | 0 | 4 |
_aKernicterus _xprevention & control |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aFrank, J W | |
| 773 | 0 |
_tPediatrics _gvol. 81 _gno. 2 _gp. 304-15 |
|
| 999 |
_c3282919 _d3282919 |
||